Senco Gold, NATCO Pharma, Godfrey Phillips, Vodafone Idea, Deepak Nitrate: Check top buzzing stocks of the day

After opening in green, the domestic equity market was trading with significant cuts in on Friday, February 14.

At 12:30 PM, the S&P BSE SENSEX was trading at 75,616.44, down 522.53 points, or 0.69%, while the NSE's NIFTY50 index was trading at 22,837.25, down 194.15 points, or 0.84%.

The jewellery chain’s consolidated net profit for the December quarter declined 69.4% to ₹33.4 crore as compared to ₹109.3 crore in the corresponding quarter of the previous fiscal year. However, its revenue from operations saw a 27.3% rise at ₹2,102.5 crore as compared to ₹1,652.2 crore in Q3FY23.

During intraday, shares of the company tanked 19.05% at ₹361.8 apiece on BSE.

The stock was trading 15.61% higher at ₹5,780 per share on the National Stock Exchange (NSE) at 11:20 am. Its market capitalisation stands at ₹30,057.95 crore. On the BSE, it gained 16.38% to ₹5,799.10 apiece.

Manappuram’s consolidated net profit declined 51.3% to ₹278.46 crore in the third quarter of the financial year 2024-2025 as against ₹525.07 crore in Q3FY24.

However, the company’s total revenue from operations grew marginally by 2.8% to ₹2559.72 crore as compared to ₹2633.1 crore in the corresponding quarter last fiscal year.

The stock plunged 13.18% to ₹1,943.30 apiece on the NSE at 9:56 am. The market capitalisation stands at ₹26,514.13 crore. On the BSE, shares were trading 13.08% lower at ₹1,944.20 per unit.

Deepak Nitrite reported a 51.45% decline in its consolidated net profit to ₹98.09 apiece in the quarter ended December 2024. In the year-ago period, the post-tax profit was ₹202.05 crore.

However, the stock pared gains later. Last seen, the share price was trading at ₹2,047.50, up 0.85%.

For the quarter ended December 31, 2024, the company reported a 10% YoY rise in its standalone sales at ₹1,998 crore. UBL had posted a profit of ₹1,823 crore in the year-ago period. EBIT, or earnings before interest and taxes, fell 24% YoY to ₹90 crore.

In early trade, the stock rose as much as 2.24% to ₹616 apiece on the National Stock Exchange. At 9:27 am, it was up 0.63% to ₹606.30 per share.

Hindalco Industries' consolidated net profit advanced 60% to ₹3,735 crore in the third quarter of the current fiscal year, compared to ₹2,331 crore in the year-ago period. The company's total income increased 10.94% to ₹58,899 crore as against ₹53,088 crore a year back.

On Thursday, the drug manufacturer cracked the lower circuit at ₹975.05 per equity price, down 19.99% on the NSE. The stock hit the lower circuit at ₹973.35 and closed at ₹973.4 on the Bombay Stock Exchange (BSE).

During the intraday trade, Lupin was trading at ₹1,945.55 apiece, falling 5.36% on BSE.

The pharma major had reported a 38.8% rise in its consolidated net profit at ₹858.9 crore for Q3FY25 against ₹618.7 crore logged in the corresponding quarter of the previous fiscal.

Sales for the quarter under review came in at ₹5,618.6 crore, up 10.6% against ₹5,079.9 crore registered in the December 2023 quarter.

In October-December period, Concord’s consolidated profit after tax fell 2% to ₹75.9 crore as compared to ₹77.6 crore in Q3FY24. Its revenue from operations advanced marginally by a percent to ₹244.2 crore as against 240.8 core in corresponding quarter previous fiscal.

At 12 PM, Concord Biotech shares was trading at ₹1,786.85 on BSE, tanking 15.31% on BSE.

The company’s EBITDA during the reporting quarter also declined by 8% to ₹98 crore as against 105.9 crore in Q3FY24.

During the intraday trade, Vodafone Idea was trading at ₹8.18 apiece, declining 5.43% on BSE.